Growth Factors of Blood Screening Market
The blood screening market size was valued at USD 2.31 billion in 2018, and the market is now projected tgrow from USD 6.63 billion by 2032, exhibiting a CAGR of 7.9% during the forecast period of 2019-2026.
The rising blood donation cases around the globe benefit the blood testing industry during this period. Government and non-profit initiatives are driving voluntary contributions and campaigns. Growing awareness of blood safety is accelerating the need for screening tests. Increased accidents and chronic diseases such as cancer are contributing thigher blood demand. Cancer treatments and accident victims often require significant blood transfusions, further fueling the blood screening market growth.
The shift tautomated molecular platforms is enhancing blood screening accuracy and speed. Automation reduces human error in detecting transfusion-transmissible infections (TTIs). These platforms are increasingly adopted by blood banks and hospitals, influencing critical medical decisions. Key players drive growth through innovative automated solutions tpropel the blood screening market share.
Comprehensive Analysis of Blood Screening Market
The blood screening market and healthcare industry is rising at an exponential rate due tits market segmentation. This market expansion effectively provides a detailed regional assessments considering the dominant supply and demand forces that impact the healthcare industry. These segmentations are methodically segregated by product type, by technology and by end user. The product type includes, Instruments, and Reagents & Kits. The technology includes, Molecular Tests and Serology Tests. The end user includes, Independent Clinical Laboratories, Hospital-based Laboratories and Others.
North America led the blood screening market, which had a size of USD 967.0 million in 2018. This dominance is driven by a rising number of blood donors, widespread adoption of blood screening processes and higher patient affordability. Strong public awareness of blood safety alscontributes tthe region's leading global market share.
The top players in the market play a crucial role in the healthcare industry assuring industrial prospectus growth and setting market standards. These players include, Bio-Rad Laboratories, Inc., Grifols, S.A., F. Hoffmann-La Roche, OrthClinical Diagnostics, BD, DiaSorin S.p.A., ThermFisher Scientific Inc., Abbott, QUOTIENT and Other Players. These market players provide a level-playing competitive landscape.
In June 2021, Grail, an American biotechnology and pharmaceutical firm, pointed out that it has synthesized the Galleri blood test, a multiple form of cancer screening diagnostic. This test was initiated in early 2020 and will be able tserve 40 t50 million people at best, the company has plans tseek full approval from the FDA in 2023.
Segmentation Table
Global Blood Screening Market Scope
Study Period 2015-2026
Base Year 2018
Forecast Period 2019-2026
Growth Rate CAGR of 7.9% from 2019 t2026
Historical Period 2015-2017
Unit Value (USD billion)
Segmentation By Product Type, Technology, End User, and Geography
By Product Type
Instruments
Reagents & Kits
By Technology
Molecular Tests
Serology Tests
By End User
Independent Clinical Laboratories
Hospital-based Laboratories
Others
By Geography
North America (U.S. and Canada)
Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia- Pacific)
Latin America (Brazil, Mexico, and Rest of Latin America)
Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 4. Key Insights
- 4.1. Technology Advances, Blood Screening Techniques
- 4.2. Key Developments: Mergers, Partnerships, New Product Launches, etc.
- 4.3. Number of Blood Donations: Key Countries, 2018
- 4.4. Regulatory Scenario, Key Regions
- 4.5. Overview: Government Initiatives Towards Blood Donations
- 5. Global Blood Screening Market Analysis, Insights and Forecast, 2015-2026
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Product Type
- 5.2.1. Instruments
- 5.2.2. Reagents & Kits
- 5.3. Market Analysis, Insights and Forecast – By Technology
- 5.3.1. Molecular Tests
- 5.3.2. Serology Tests
- 5.4. Market Analysis, Insights and Forecast – By End User
- 5.4.1. Independent Clinical Laboratories
- 5.4.2. Hospital-based Laboratories
- 5.4.3. Others
- 5.5. Market Analysis, Insights and Forecast – By Country
- 5.5.1. North America
- 5.5.2. Europe
- 5.5.3. Asia Pacific
- 5.5.4. Latin America
- 5.5.5. Middle East & Africa
- 6. North America Blood Screening Market Analysis, Insights and Forecast, 2015-2026
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast – By Product Type
- 6.2.1. Instruments
- 6.2.2. Reagents & Kits
- 6.3. Market Analysis, Insights and Forecast – By Technology
- 6.3.1. Molecular Tests
- 6.3.2. Serology Tests
- 6.4. Market Analysis, Insights and Forecast – By End User
- 6.4.1. Independent Clinical Laboratories
- 6.4.2. Hospital-based Laboratories
- 6.4.3. Others
- 6.5. Market Analysis, Insights and Forecast – By Country
- 6.5.1. U.S.
- 6.5.2. Canada
- 7. Europe Blood Screening Market Analysis, Insights and Forecast, 2015-2026
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast – By Product Type
- 7.2.1. Instruments
- 7.2.2. Reagents & Kits
- 7.3. Market Analysis, Insights and Forecast – By Technology
- 7.3.1. Molecular Tests
- 7.3.2. Serology Tests
- 7.4. Market Analysis, Insights and Forecast – By End User
- 7.4.1. Independent Clinical Laboratories
- 7.4.2. Hospital-based Laboratories
- 7.4.3. Others
- 7.5. Market Analysis, Insights and Forecast – By Country/ Sub-region
- 7.5.1. U.K.
- 7.5.2. Germany
- 7.5.3. France
- 7.5.4. Spain
- 7.5.5. Italy
- 7.5.6. Scandinavia
- 7.5.7. Rest of Europe
- 8. Asia Pacific Blood Screening Market Analysis, Insights and Forecast, 2015-2026
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast – By Product Type
- 8.2.1. Instruments
- 8.2.2. Reagents & Kits
- 8.3. Market Analysis, Insights and Forecast – By Technology
- 8.3.1. Molecular Tests
- 8.3.2. Serology Tests
- 8.4. Market Analysis, Insights and Forecast – By End User
- 8.4.1. Independent Clinical Laboratories
- 8.4.2. Hospital-based Laboratories
- 8.4.3. Others
- 8.5. Market Analysis, Insights and Forecast – By Country/ Sub-region
- 8.5.1. Japan
- 8.5.2. China
- 8.5.3. India
- 8.5.4. Australia
- 8.5.5. Southeast Asia
- 8.5.6. Rest of Asia Pacific
- 9. Latin America Blood Screening Market Analysis, Insights and Forecast, 2015-2026
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast – By Product Type
- 9.2.1. Instruments
- 9.2.2. Reagents & Kits
- 9.3. Market Analysis, Insights and Forecast – By Technology
- 9.3.1. Molecular Tests
- 9.3.2. Serology Tests
- 9.4. Market Analysis, Insights and Forecast – By End User
- 9.4.1. Independent Clinical Laboratories
- 9.4.2. Hospital-based Laboratories
- 9.4.3. Others
- 9.5. Market Analysis, Insights and Forecast – By Country/ Sub-region
- 9.5.1. Brazil
- 9.5.2. Mexico
- 9.5.3. Rest of Latin America
- 10. Middle East & Africa Blood Screening Market Analysis, Insights and Forecast, 2015-2026
- 10.1. Key Findings / Summary
- 10.2. Market Analysis, Insights and Forecast – By Product Type
- 10.2.1. Instruments
- 10.2.2. Reagents & Kits
- 10.3. Market Analysis, Insights and Forecast – By Technology
- 10.3.1. Molecular Tests
- 10.3.2. Serology Tests
- 10.4. Market Analysis, Insights and Forecast – By End User
- 10.4.1. Independent Clinical Laboratories
- 10.4.2. Hospital-based Laboratories
- 10.4.3. Others
- 10.5. Market Analysis, Insights and Forecast – By Country/ Sub-region
- 10.5.1. GCC Countries
- 10.5.2. South Africa
- 10.5.3. Rest of Middle East & Africa
- 11. Competitive Analysis
- 11.1. Key Industry Developments
- 11.2. Global Market Share Analysis (2018)
- 11.3. Company Profiles (Overview, Products, SWO, Recent Developments, Strategies, Financials (based on availability))
- 11.3.1. Bio-Rad Laboratories, Inc
- 11.3.1.1. Overview,
- 11.3.1.2. Products,
- 11.3.1.3. SWO,
- 11.3.1.4. Recent Developments,
- 11.3.1.5. Strategies,
- 11.3.1.6. Financials (based on availability)
- 11.3.2. Grifols, S.A.
- 11.3.2.1. Overview,
- 11.3.2.2. Products,
- 11.3.2.3. SWO,
- 11.3.2.4. Recent Developments,
- 11.3.2.5. Strategies,
- 11.3.2.6. Financials (based on availability)
- 11.3.3. F. Hoffmann-La Roche
- 11.3.3.1. Overview,
- 11.3.3.2. Products,
- 11.3.3.3. SWO,
- 11.3.3.4. Recent Developments,
- 11.3.3.5. Strategies,
- 11.3.3.6. Financials (based on availability)
- 11.3.4. Ortho Clinical Diagnostics
- 11.3.4.1. Overview,
- 11.3.4.2. Products,
- 11.3.4.3. SWO,
- 11.3.4.4. Recent Developments,
- 11.3.4.5. Strategies,
- 11.3.4.6. Financials (based on availability)
- 11.3.5. DiaSorin S.p.A.
- 11.3.5.1. Overview,
- 11.3.5.2. Products,
- 11.3.5.3. SWO,
- 11.3.5.4. Recent Developments,
- 11.3.5.5. Strategies,
- 11.3.5.6. Financials (based on availability)
- 11.3.6. BD
- 11.3.6.1. Overview,
- 11.3.6.2. Products,
- 11.3.6.3. SWO,
- 11.3.6.4. Recent Developments,
- 11.3.6.5. Strategies,
- 11.3.6.6. Financials (based on availability)
- 11.3.7. Thermo Fisher Scientific Inc.
- 11.3.7.1. Overview,
- 11.3.7.2. Products,
- 11.3.7.3. SWO,
- 11.3.7.4. Recent Developments,
- 11.3.7.5. Strategies,
- 11.3.7.6. Financials (based on availability)
- 11.3.8. Abbott
- 11.3.8.1. Overview,
- 11.3.8.2. Products,
- 11.3.8.3. SWO,
- 11.3.8.4. Recent Developments,
- 11.3.8.5. Strategies,
- 11.3.8.6. Financials (based on availability)
- 11.3.9. Quotient
- 11.3.9.1. Overview,
- 11.3.9.2. Products,
- 11.3.9.3. SWO,
- 11.3.9.4. Recent Developments,
- 11.3.9.5. Strategies,
- 11.3.9.6. Financials (based on availability)
- 11.3.10. Other Players
- 11.3.10.1. Overview,
- 11.3.10.2. Products,
- 11.3.10.3. SWO,
- 11.3.10.4. Recent Developments,
- 11.3.10.5. Strategies,
- 11.3.10.6. Financials (based on availability)
- 12. Strategic Recommendations "
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook